Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models.

Taofeek Kunle OwonikokoGuojing ZhangShenila B LallaniZhengjia ChenDeborah E MartinsonFadlo R KhuriSagar LonialAdam MarcusShi-Yong Sun

Published in: PloS one (2019)

Our findings provide support for the clinical evaluation of everolimus and pasireotide in thyroid cancer and other neuroendocrine tumors.

Keyphrases